Silviu Itescu is the Director of Mesoblast Limited, an Australian regenerative medicine company focused on developing allogeneic cellular medicines.
Silviu Itescu is the Director of Mesoblast Limited, an Australian regenerative medicine company focused on developing allogeneic cellular medicines for severe inflammatory conditions. He has discussed the company's product pipeline, including treatments for end-stage heart failure, in investor presentations. Itescu has also increased his stake in the company through option exercises.
Full founder directory · Investor directory · Company funding database · Fundraising library